Eunice Y. Lau

2.5k total citations
37 papers, 2.0k citations indexed

About

Eunice Y. Lau is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Eunice Y. Lau has authored 37 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 16 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Eunice Y. Lau's work include Cancer, Hypoxia, and Metabolism (8 papers), MicroRNA in disease regulation (5 papers) and Cancer Cells and Metastasis (5 papers). Eunice Y. Lau is often cited by papers focused on Cancer, Hypoxia, and Metabolism (8 papers), MicroRNA in disease regulation (5 papers) and Cancer Cells and Metastasis (5 papers). Eunice Y. Lau collaborates with scholars based in Hong Kong, China and United States. Eunice Y. Lau's co-authors include Terence K. Lee, Irene Oi‐Lin Ng, Stephanie Ma, Jessica Lo, Nicole P. Ho, Bowie Y. Cheng, Man Tong, Chi Ho Lin, Rachel Hiu Ha Ching and Hoi-Wing Leung and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Hepatology and Cancer Research.

In The Last Decade

Eunice Y. Lau

36 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eunice Y. Lau Hong Kong	20	1.1k	755	624	397	254	37	2.0k
Laia Caja Sweden	23	1.1k 1.0×	434 0.6×	744 1.2×	347 0.9×	281 1.1×	39	1.9k
Yuezhen Deng China	20	1.1k 1.0×	646 0.9×	421 0.7×	330 0.8×	173 0.7×	34	1.8k
Yuquan Xiong United States	16	1.1k 0.9×	442 0.6×	520 0.8×	657 1.7×	237 0.9×	20	1.9k
Juanjuan Shan China	24	1.4k 1.3×	735 1.0×	635 1.0×	208 0.5×	191 0.8×	41	2.1k
Géraldine Gentric France	13	951 0.8×	602 0.8×	752 1.2×	408 1.0×	166 0.7×	17	1.8k
Kwan Ho Tang Hong Kong	14	1.5k 1.3×	870 1.2×	1.3k 2.1×	387 1.0×	330 1.3×	20	2.4k
Jiang‐Sha Zhao China	13	871 0.8×	520 0.7×	386 0.6×	267 0.7×	152 0.6×	18	1.4k
Shuang‐Jian Qiu China	21	1.4k 1.2×	1.2k 1.6×	428 0.7×	224 0.6×	378 1.5×	36	2.3k
Janelle Simon United States	11	993 0.9×	379 0.5×	727 1.2×	504 1.3×	114 0.4×	13	2.0k
Franziska van Zijl Austria	11	824 0.7×	371 0.5×	604 1.0×	193 0.5×	231 0.9×	13	1.6k

Countries citing papers authored by Eunice Y. Lau

Since Specialization

Citations

This map shows the geographic impact of Eunice Y. Lau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eunice Y. Lau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eunice Y. Lau more than expected).

Fields of papers citing papers by Eunice Y. Lau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eunice Y. Lau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eunice Y. Lau. The network helps show where Eunice Y. Lau may publish in the future.

Co-authorship network of co-authors of Eunice Y. Lau

This figure shows the co-authorship network connecting the top 25 collaborators of Eunice Y. Lau. A scholar is included among the top collaborators of Eunice Y. Lau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eunice Y. Lau. Eunice Y. Lau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Law, Chun Yiu, David Tak Wai Lui, Eunice Y. Lau, et al.. (2024). A missense variant in SLC12A3 gene enhances aberrant splicing causing Gitelman syndrome. Clinica Chimica Acta. 564. 119924–119924. 1 indexed citations

Hui, Pui Wah, et al.. (2023). Prenatal diagnosis of Myhre syndrome with a heterozygous pathogenic variant in SMAD4 gene presented with thick nuchal translucency and cardiac abnormalities. Prenatal Diagnosis. 43(10). 1366–1369. 3 indexed citations

Zhou, Lei, Martina Mang Leng Lei, Hoi-Wing Leung, et al.. (2022). Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular Carcinoma. Cancer Research. 82(17). 3102–3115. 71 indexed citations

Lei, Martina Mang Leng, Carmen Oi Ning Leung, Eunice Y. Lau, et al.. (2022). SCYL3, as a novel binding partner and regulator of ROCK2, promotes hepatocellular carcinoma progression. JHEP Reports. 5(1). 100604–100604. 11 indexed citations

Leung, Hoi-Wing, Carmen Oi Ning Leung, Eunice Y. Lau, et al.. (2021). EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma. Cancer Research. 81(12). 3229–3240. 102 indexed citations

Ho, Nicole P., Carmen Oi Ning Leung, Tin Lok Wong, et al.. (2021). The interplay of UBE2T and Mule in regulating Wnt/β-catenin activation to promote hepatocellular carcinoma progression. Cell Death and Disease. 12(2). 148–148. 27 indexed citations

Cho, Sun Young, et al.. (2020). Novel PPOX exonic mutation inducing aberrant splicing in a patient with homozygous variegate porphyria. Clinica Chimica Acta. 512. 117–120. 3 indexed citations

Leung, Hoi-Wing, Eunice Y. Lau, Carmen Oi Ning Leung, et al.. (2020). NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma. Cancer Letters. 476. 48–56. 46 indexed citations

Nath, Aritro, Eunice Y. Lau, Adam M Lee, et al.. (2019). Discovering long noncoding RNA predictors of anticancer drug sensitivity beyond protein-coding genes. Proceedings of the National Academy of Sciences. 116(44). 22020–22029. 31 indexed citations

10.

Leung, Carmen Oi Ning, Man Tong, Noélia Che, et al.. (2019). Overriding Adaptive Resistance to Sorafenib Through Combination Therapy With Src Homology 2 Domain–Containing Phosphatase 2 Blockade in Hepatocellular Carcinoma. Hepatology. 72(1). 155–168. 73 indexed citations

11.

Cheng, Bowie Y., Eunice Y. Lau, Hoi-Wing Leung, et al.. (2018). IRAK1 Augments Cancer Stemness and Drug Resistance via the AP-1/AKR1B10 Signaling Cascade in Hepatocellular Carcinoma. Cancer Research. 78(9). 2332–2342. 83 indexed citations

12.

Lau, Eunice Y., et al.. (2018). Abstract 3067: The novel function of keratin 14 (KRT14) in regulating cancer stem cell properties in lung adenocarcinoma. Cancer Research. 78(13_Supplement). 3067–3067. 1 indexed citations

13.

Lau, Eunice Y., Nicole P. Ho, & Terence K. Lee. (2017). Cancer Stem Cells and Their Microenvironment: Biology and Therapeutic Implications. Stem Cells International. 2017. 1–11. 137 indexed citations

14.

Lau, Eunice Y., Hoi-Wing Leung, Jessica Lo, et al.. (2017). Stearoyl-CoA desaturase regulates sorafenib resistance via modulation of ER stress-induced differentiation. Journal of Hepatology. 67(5). 979–990. 139 indexed citations

15.

Lau, Eunice Y., Jessica Lo, Bowie Y. Cheng, et al.. (2016). Cancer-Associated Fibroblasts Regulate Tumor-Initiating Cell Plasticity in Hepatocellular Carcinoma through c-Met/FRA1/HEY1 Signaling. Cell Reports. 15(6). 1175–1189. 269 indexed citations

16.

Lo, Jessica, Eunice Y. Lau, Rachel Hiu Ha Ching, et al.. (2015). Nuclear factor kappa B–mediated CD47 up‐regulation promotes sorafenib resistance and its blockade synergizes the effect of sorafenib in hepatocellular carcinoma in mice. Hepatology. 62(2). 534–545. 156 indexed citations

17.

Liu, Ji, Eunice Y. Lau, Jiezhong Chen, et al.. (2014). Polysaccharopeptide enhanced the anti-cancer effect of gamma-tocotrienol through activation of AMPK. BMC Complementary and Alternative Medicine. 14(1). 303–303. 17 indexed citations

18.

Lau, Eunice Y. & Nasiya Ahmed. (2012). Fracture Risk and Bone Mineral Density Reduction Associated with Proton Pump Inhibitors. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 32(1). 67–79. 37 indexed citations

19.

Ng, Simon S.M., et al.. (2010). Role of voltage‐gated potassium channels in the fate determination of embryonic stem cells. Journal of Cellular Physiology. 224(1). 165–177. 41 indexed citations

20.

Lau, Eunice Y., et al.. (2010). Effects of hyperpolarization-activated cyclic nucleotide-gated (HCN) channel blockers on the proliferation and cell cycle progression of embryonic stem cells. Pflügers Archiv - European Journal of Physiology. 461(1). 191–202. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact